Conditions Eligible for Direct Prescription:

• Oncology: Patients undergoing active chemotherapy or radiation.

• Epilepsy: Both pediatric and adult.

• Crohn’s Disease and Ulcerative Colitis.

• Dementia.

• Autism: For minors (under specific clinical guidelines).

• Terminal Illness: Palliative care and end-of-life comfort.

Note: Psychiatric conditions (like PTSD) and Chronic Pain still require the traditional individual license issued by YAKAR.

Who is Eligible? (Procedure 106)

Eligibility is strictly defined by the Ministry of Health’s Procedure 106. Key categories include: 1. Chronic Pain: At least one year of documented treatment in a pain clinic and failure of at least two conventional analgesic medications. 2. PTSD: The condition must be documented for over 3 years, with significant disability, and after trying at least two pharmacological treatments and psychotherapy. 3. Neurology: Conditions such as Multiple Sclerosis, Parkinson’s, and Tourette Syndrome. 4. Gastroenterology: Severe inflammatory bowel diseases where biologics have failed or are unsuitable.

The 2026 Application Process

1. Medical Documentation

The "burden of proof" is on the patient. You must provide a comprehensive medical file showing you have "exhausted" conventional treatments. Keep every pharmacy receipt and doctor's summary.

2. Specialist Consultation

Only a specialist in the relevant field (e.g., an oncologist for cancer or a neurologist for MS) can initiate the request. Family doctors (Rofe Mishpacha) cannot issue cannabis permits.

3. Submission

The doctor submits a digital application. For "Prescription Model" patients, the voucher is issued instantly. For others, YAKAR reviews the file. In 2026, the average processing time is 14 to 45 days.

Costs and Distribution

Medical cannabis is sold exclusively in licensed pharmacies (e.g., Super-Pharm, Be, and specialized independent pharmacies).

• Pricing: Not subsidized by the National Health Basket. Expect to pay between 140 and 280 NIS per 10-gram pack.

• Strains: Products are categorized by their THC (T) and CBD (C) ratios (e.g., T20/C4 is high THC, while T1/C20 is high CBD).

Driving and the Law: 2026 Updates

Driving while using medical cannabis remains a complex legal issue in Israel.

• Zero Tolerance: Technically, having THC metabolites in your blood while driving can lead to a DUI charge.

• 2025/2026 Adjustments: New guidelines have been introduced for patients using low-THC oils. There is also an ongoing pilot program allowing some patients to drive 6-12 hours after inhalation, provided they carry a valid permit and meet specific clinical criteria.

Expert Advice: If you are a licensed user and a driver, always consult a specialized traffic lawyer to understand your specific risks.

Employment Rights

Employers generally cannot discriminate against employees who hold a medical cannabis license. However, for "safety-sensitive" roles (pilots, heavy machinery operators, surgeons), the employer has the right to restrict certain duties. For most office-based roles, your license is protected as private medical information.

RofeRank Expert Tip

Always check the "Batch Number" on your pharmacy packaging. Israeli medical cannabis is strictly tested for heavy metals and pesticides. If you experience side effects, your doctor can use this batch number to report the issue to the Ministry of Health.

Medical cannabis in Israel is a clinical tool designed to restore quality of life. Use it responsibly and always under the guidance of your medical specialist.